Allen JavanpourIntern, RNA Production Angela StassinopoulosSenior Research Associate, RNA Production Angel LeuSenior Research Associate, Frontier Science Arisa Iga CaleResearch Associate I, RNA Production Banibrata (Bani) GhoshSenior Research Associate, Analytical Bijan GodarziResearch Associate I, Frontier Science Carina WimerResearch Associate II, Drug Discovery Carlos Perez-GarciaSenior Scientist, Drug Discovery Cheryl ChanIntern, Analytical Development Christine (Christy) EsauSenior Director, Translational Biology Christopher GaviganIntern, Frontier Science Daiki MatsudaSenior Scientist, Frontier Science Daniel HwangSenior Staff Accountant Flora HuynhSenior Research Associate, Analytical/Lab Coordinator Hanyi (Han) ChangResearch Associate I, Formulation Development Hari BhaskaranScientist I, Transnational Biology Inna KoukharevaSenior Manager, Analytical Development Jae Heon (Jay) KimIntern, Formulation Development Jared DavisDirector, RNA Process Development Jerel VegaSenior Research Associate, Formulation Development John SproulShipping/Receiving & Inventory Control Coordinator Jennifer PerkinsExecutive Assistant Jonathan BushResearch Associate I, Formulation Development Rebecque LabaVice President of Finance & Operations
Rebecque J. Laba joined Arcturus Therapeutics in August 2017 and serves as Vice President of Finance and Operations. Prior to joining Arcturus, Ms. Laba served as Vice President, Finance and Corporate Operations at Celladon Corporation where she led the company through its Initial Public Offering (IPO). Prior to Celladon, Rebecque served as Sr. Director, Finance and Administration at Idun Pharmaceuticals which was acquired by Pfizer in 2005. Ms. Laba has over 18 years of experience in leadership roles in life science and over 25 years of experience in finance and operations.
Joseph E. PaynePresident & Chief Executive Officer Justin PiIntern, Formulation Development Kiyoshi TachikawaSenior Research Fellow Kim McAdenPurchasing Manager Lishuang (Lily) XuResearch Associate II, Drug Discovery Marciano SabladScientist II, Translational Biology Michael (Mike) CuddyResearch Associate III, Drug Discovery Michelle NguyenResearch Associate I, Analytical Development Mike MatsumotoResearch Associate I, Drug Discovery Neda SafarzadehAssociate Director of Investor Relations & Public Relations/Marketing Pad ChivukulaChief Operating Officer & Chief Scientific Officer Pattraranee (Patty) LimphongSenior Manager, RNA Process Development Priya KarmaliSr. Director, Pharmaceutical Development Rajesh MukthavaramScientist I, Formulation Development Ramon Diaz TrellesScientist II, Frontier Science Robin LeeSenior Research Associate, Formulation Development Ruolei (Raymond) DongIntern, Formulation Development Samuel LeeResearch Associate I, RNA Process Development Samantha MurphyAssociate Director, Business Development Scott RobertsSenior Manager, CMC Sharon LeeResearch Associate I, Frontier Science Mark HerbertVP of Business Development & Alliance Managment
Mark R. Herbert joined Arcturus Therapeutics in November 2015 and serves as Vice President of Business Development and Alliance Management. Prior to joining Arcturus, Mr. Herbert served as Head of US Business Development and Sales at STA, WuXi AppTec’s small molecule development and manufacturing division, where he was responsible for all North American business development and marketing activities. Prior to WuXi AppTec, Mark served as Director of Pharmaceutical Sciences at Aragon Pharmaceuticals which was acquired by Johnson & Johnson for $1B in 2013.
Wendy TaylorDirector, Project Management Steven LyResearch Associate I, Analytical Development Nancy FuselliDirector, Quality & Regulatory Affairs Stuart CollinsonExecutive Chair of the Board ThanhChau DamResearch Associate II, Translational Biology Thu LeIntern, Formulation Development Tran TrinhResearch Associate I, RNA Process Development Kumar RajappanPrincipal Scientist, Chemistry Jose GonzalesResearch Associate I, Translational Biology Xuequn (Helen) HuaAssociate Director, Translational Biology Yanjie (Belle) BaoScientist II, Formulation Development Yi KuoIntern, RNA Production Adam PavlicekBioinformatics Consultant Carol HidalgoHuman Resources Consultant Michael HodgesR&D & Medical Consultant Steve TanisChemistry Consultant
Tom RobbinsFinance Consultant
Founded in 2013 and based in San Diego, California, Arcturus Therapeutics is an industry leader in the application of RNA technologies for the treatment of disease and improved quality of life. The company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. Backed by a management team with extensive experience in the discovery and development of RNA medicines, Arcturus is on the forefront of research and development of RNA chemistry and delivery technologies.
January 7, 2018 Arcturus Therapeutics to Present in a Panel Discussion at East/West CEO Conference Called “Challenges and Opportunities in Biotech” on Sunday, Jan 7th 2018, from 11:20 am - 11:50 am. read more
January 5, 2018 Johnson & Johnson Innovation Champions Leading Edge Science with 15 New Collaborations with Potential to Impact Patients' Lives read more
January 4, 2018 CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-Mediated mRNA Therapeutics read more